MEDPAL AI is trading 8.2% down at £4.70 in the October 20, 2026 session, with no clear catalyst identified for the decline. - The latest company update described New Health’s Mounjaro ranking and customer growth; it did not identify a cause for the share-price move. - The provided sector trend was positive, while wider-market information was mixed. - No trading-volume figure is established by the supplied price context.